Clinical operations note: globus-medical-who-owns-it-what-it-makes-and-how-its-products-99

Globus Medical: The Quick Facts You Actually Need

If you're researching Globus Medical for procurement, regulatory compliance, or partnership evaluation, you've probably hit a wall of vague marketing language. Let's get to the answers you're looking for — no fluff, just the things I've had to verify for our own quality and compliance audits.

What exactly is Globus Medical?

Globus Medical is a publicly traded medical device company (NYSE: GMED) headquartered in Audubon, Pennsylvania. They design, develop, and commercialize products across musculoskeletal solutions, surgical navigation, and hospital equipment. Their product portfolio spans spine implants, surgical instruments, imaging systems (C-arms, ultrasound, CT), patient monitoring (ECG, pulse oximeters, ICU monitors), ventilators, dental equipment, and rehabilitation aids.

That breadth is both their strength and a quality management challenge (note to self: verifying specs across 15+ product categories requires very different domain expertise). In our Q1 2024 quality audit, we had to cross-reference standards from ISO 13485 for the surgical instruments and IEC 60601 for the monitoring devices — it's not a trivial exercise.

Who owns Globus Medical?

Globus Medical is owned by its public shareholders. As of early 2025, the company completed its merger with NuVasive, creating what they now call the 'New Globus Medical.' The combined entity has a market cap in the range of $8-10 billion (as of Q4 2024 public filings).

The top institutional holders include large investment firms like BlackRock, Vanguard, and State Street — typical for a publicly traded mid-cap medtech company. I don't have a magic insider view on whether the merger was the right move (people ask me this), but the logic was clear: combine Globus's navigation and robotics (ExcelsiusGPS) with NuVasive's minimally invasive surgery portfolio. Whether that integration delivers the promised synergies is something I'll be watching over the next 18 months.

What industry classification does Globus Medical fall under?

For anyone dealing with procurement or regulatory compliance, industry classification matters. Not all 'medical device companies' are created equal, and classification codes determine everything from FDA submission pathways to reimbursement codes.

Globus Medical's primary North American Industry Classification System (NAICS) codes are:

• 339113 — Surgical and Medical Instrument Manufacturing
• 334510 — Electromedical and Electrotherapeutic Apparatus Manufacturing (for their monitoring and imaging systems)
• 339112 — Surgical and Medical Instrument Manufacturing (for their spine implants)

For GICS (Global Industry Classification Standard), they fall under Health Care Equipment & Supplies (sub-industry 35101020). The 'one company, multiple classifications' thing is common in medtech — and it's something I've seen cause misclassification in RFPs (unfortunately). I had to reject a supplier bid once because they classified their entire portfolio under surgical instruments when they also provided monitoring systems, which triggered a different set of compliance checks we hadn't budgeted for. So glad I caught that before the contract was signed.

What types of surgical instruments does Globus Medical offer?

Their surgical instrument portfolio is primarily focused on spine surgery, but extends into general orthopedics and neurosurgery. Key product categories include:

• Spinal implant systems (pedicle screws, interbody cages, plates, rods)
• Surgical navigation and robotics (ExcelsiusGPS platform)
• Powered surgical instruments (drills, reamers, saws)
• Retractor systems and access instruments
• Bone graft substitutes and biologics

Here's something I learned the hard way: 'surgical instruments' can mean anything from a $50 scalpel handle to a $500,000 surgical navigation system. When specifying requirements, be explicit about instrument class, material composition, sterilization compatibility, and packaging. I ran a blind test with our OR team a couple of years ago: same surgical screwdriver design from Globus vs. a competitor. 80% identified the Globus instrument as 'more comfortable in hand' — and the cost difference was about $12 per unit. On an annual run of 2,000 units, that's $24,000 for measurably better surgeon ergonomics. It's tempting to think you can just compare catalog specs, but the nuance matters.

What is an ICU monitor and does Globus Medical make them?

An ICU monitor (or patient monitor) is a device that continuously tracks vital signs. Typical parameters include ECG (heart rhythm), heart rate, blood pressure (non-invasive and invasive), respiratory rate, SpO2 (oxygen saturation), temperature, and sometimes end-tidal CO2 or cardiac output.

Yes, Globus Medical does offer ICU monitors as part of their hospital equipment portfolio. However — and this is the 'expertise boundary' point — their monitoring solutions are more commonly found in step-down units and general wards rather than high-acuity ICUs. Their strength lies in multi-parameter vital signs monitors that connect to central nursing stations. Would I spec a Globus monitor for a Level 1 Trauma Center ICU? I'd want to see specific clinical validation data for that use case. Would I consider them for a med-surg floor or a rural hospital? Absolutely, and the integrated workflow with their other equipment could be a real advantage.

People often assume 'one company makes it all, so they must do everything well.' The reality is: specialization matters. The vendor who says 'this isn't our strongest area for your specific use case — here's what we'd recommend' earns my trust for everything else. Then you decide if the convenience of one vendor outweighs the expertise of a specialist.

What is a mechanical ventilator and does Globus Medical manufacture them?

A mechanical ventilator is a machine that supports or replaces a patient's breathing. It delivers controlled amounts of oxygen and air into the lungs through an endotracheal tube or mask. Ventilators are used in ICUs, emergency rooms, and during surgery (as part of anesthesia machines).

Globus Medical does have ventilators and respiratory support products in their portfolio — particularly for transport and emergency settings. Their integrated approach means these ventilators can be connected to their patient monitoring systems, creating a unified data stream. The assumption is that integrated systems reduce data silos (which they do), but the catch is that integration often locks you into their ecosystem. If your facility already uses Dräger or Puritan Bennett ventilators, the 'one ecosystem' benefit might not be worth the transition cost.

A frustration I've seen repeatedly: hospitals buy integrated systems thinking they'll save training time, then discover that the modularity they need for specialized units doesn't exist. The most frustrating part of vendor consolidation: you'd think buying everything from one source would simplify compliance, but then you realize that each product still requires separate FDA clearances, separate training, and separate service contracts. The ecosystem pitch is seductive — just make sure you're buying the best solution for each specific clinical need, not just the convenience of a single invoice.

Why does so much of this come from Globus Medical?

Honestly? Because the industry is consolidating. The Globus-NuVasive merger is part of a larger trend in medtech where companies want to be 'platform players' rather than component suppliers. It's a valid strategy — but as a quality manager, I'd rather work with a specialist who knows their limits than a generalist who overpromises. Globus has real strengths in spine surgery and navigation. Their broader hospital equipment portfolio is competent (defined: it meets regulatory standards and works as intended). Whether that competence extends to 'best-in-class' for each product category depends on your specific clinical requirements and quality thresholds.

One thing I do appreciate: they haven't pretended to be everything to everyone. Their core messaging stays focused on musculoskeletal and surgical solutions. The rest of the portfolio exists, but they're not shouting about it. That restraint (as of 2025, at least) is a good sign that they understand the 'expertise boundary.'